Novavax vaccine works well except on N501Y.V2 South Africa variant
An early analysis in Britain found that the Novavax vaccine had an efficacy rate of nearly 90 percent. But in a small South Africa trial, the efficacy rate dropped to just under 50 percent.
https://www.nytimes.com/2021/01/28/health/covid-vaccine-novavax-south-africa.html
Image by Arek Socha from Pixabay
** This post was originally published on January 28, 2021 **